- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medeze Group PCL (MEDEZE)
The Medeze PCL share price today is 6.55, view BK MEDEZE stock exchange data. Track the latest Medeze PCL share price with real-time updates on MEDEZE stock performance including market cap, day range, 52-week range and dividend yield. Access MEDEZE charts, earnings dates and analyst estimates to support your investment decisions.
Thailand
Currency in THB
6.55
+0.10(+1.55%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.40
6.60
52 wk Range
6.00
7.45
MEDEZE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.406.60
52 wk Range
6.007.45
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.44%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.44%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MEDEZE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
8.05
Upside
+22.90%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 8.05
(+22.90% Upside)
Earnings
Latest Release
11-08-2026
EPS / Forecast
0.04 / --
Revenue / Forecast
159M / --
Compare MEDEZE to Peers and Sector
Metrics to compare | MEDEZE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEDEZEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 48.7x | 17.6x | −0.3x | |
PEG Ratio | −0.84 | 0.02 | 0.00 | |
Price/Book | 2.3x | 1.6x | 2.6x | |
Price / LTM Sales | 9.6x | 1.7x | 3.1x | |
Upside (Analyst Target) | 22.0% | 14.4% | 50.4% | |
Fair Value Upside | Unlock | 20.7% | 6.4% | Unlock |
Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, Philippines, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells. In addition, the company is involved in research, develops, and collects data on all types of human cellular activities and medical laboratory tests. Further, the company sells dietary supplements, cosmetics, and dermo cosmetics. Medeze Group Public Company Limited was founded in 2010 and is based in Nakhon Pathom, Thailand.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Medeze PCL (MEDEZE) Share Price Today?
The Medeze PCL share price today is 6.55.
What is the current Medeze PCL (MEDEZE) share price and day range?
As of 19-08-2026, the Medeze PCL share price is 6.55, with a previous close of 6.45. The share price has ranged from 6.40 to 6.60 today, while the 52-week range spans from 6.00 to 7.45.
What Is the Medeze PCL Market Cap?
As of today, Medeze PCL market cap is 6.89B.
Does Medeze PCL Pay Dividends? What's The Current Dividend Yield?
The Medeze PCL dividend yield is 2.44%.
What Is the Medeze PCL (MEDEZE) Share Price Target?
The average 12-month share price target for Medeze PCL is 8.05, with a high estimate of 9.3 and a low estimate of 6.8. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +22.90% Upside potential.
What Is Medeze PCL's Earnings Per Share (TTM)?
The Medeze PCL EPS (TTM) is 0.13.
When Is the Next Medeze PCL Earnings Date?
Medeze PCL will release its next earnings report on 17-11-2026.
From a Technical Analysis Perspective, Is MEDEZE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Medeze PCL Trade On?
Medeze PCL is listed and trades on the Thailand Stock Exchange.
What Is the Stock Symbol for Medeze PCL?
The stock symbol for Medeze PCL is "MEDEZE."
How Many Times Has Medeze PCL Stock Split?
Medeze PCL has split 0 times.
How Many Employees Does Medeze PCL Have?
Medeze PCL has 200 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.